


Healthcare Industry NewsFeed
HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
HSMN NewsFeed - 27 Dec 2016
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
HSMN NewsFeed - 23 Dec 2016
FUSE MEDICAL, INC. Announces $720,000 Capital Investment and New Leadership
FUSE MEDICAL, INC. Announces $720,000 Capital Investment and New Leadership
HSMN NewsFeed - 22 Dec 2016
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
HSMN NewsFeed - 22 Dec 2016
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
HSMN NewsFeed - 19 Dec 2016
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer
HSMN NewsFeed - 19 Dec 2016
Masimo Announces FDA 510(k) Clearance for TFA-1(TM) Single-Patient-Use Forehead Sensor
Masimo Announces FDA 510(k) Clearance for TFA-1(TM) Single-Patient-Use Forehead Sensor
HSMN NewsFeed - 16 Dec 2016
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
HSMN NewsFeed - 14 Dec 2016
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced(TM) Allograft
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced(TM) Allograft
HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
